87

Hematology&Oncology
Sub Categories on Hematology&Oncology
Latest Articles
Novel oncolytic immunotherapy shows promise for patients with bladder cancer

Novel oncolytic immunotherapy shows promise for patients with bladder cancer

byMayo ClinicCredit: AI-generated imageA Mayo Clinic Comprehensive Cancer Center researcher will share findings from a late-breaking abstract at the2024 Society of Urologic Oncology Annual

Novel oncolytic immunotherapy shows promise for patients with bladder cancer

byMayo ClinicCredit: AI-generated imageA Mayo Clinic Comprehensive Cancer Center researcher will share findings from a late-breaking abstract at the2024 Society of Urologic Oncology Annual
Researchers map genetic variants associated with pancreatic cancer in Brazilian patients

Researchers map genetic variants associated with pancreatic cancer in Brazilian patients

Researchers map genetic variants associated with pancreatic cancer in Brazilian patientsby Karina Ninni,FAPESPSolar explosion graph depicting spectrum of PGVs and VUSs in pancreatic cancer patie

Researchers map genetic variants associated with pancreatic cancer in Brazilian patients

Researchers map genetic variants associated with pancreatic cancer in Brazilian patientsby Karina Ninni,FAPESPSolar explosion graph depicting spectrum of PGVs and VUSs in pancreatic cancer patie
Early results from a trial of active surveillance for low-risk ductal carcinoma in situ are 'reassuring'

Early results from a trial of active surveillance for low-risk ductal carcinoma in situ are 'reassuring'

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainResearchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described ear

Early results from a trial of active surveillance for low-risk ductal carcinoma in situ are 'reassuring'

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainResearchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described ear
Prioritizing potentially cancer-causing mutations in real-world cancer genomics

Prioritizing potentially cancer-causing mutations in real-world cancer genomics

byHiroshima UniversityOverview of a framework for prioritizing variants of uncertain significance (VUS) identified by comprehensive genomic profiling (CGP), based on real-world data from 2,172 tests s

Prioritizing potentially cancer-causing mutations in real-world cancer genomics

byHiroshima UniversityOverview of a framework for prioritizing variants of uncertain significance (VUS) identified by comprehensive genomic profiling (CGP), based on real-world data from 2,172 tests s
Researchers discover 'crosstalk' mechanism in two key breast cancer molecules

Researchers discover 'crosstalk' mechanism in two key breast cancer molecules

byUniversity of LiverpoolIntegrin αVβ6recruits HER2 and a trafficking regulatory subnetwork comprising RAB5/RAB7A/GDI2 in HER2+ breast cancer cells. Credit:Science Advances(202

Researchers discover 'crosstalk' mechanism in two key breast cancer molecules

byUniversity of LiverpoolIntegrin αVβ6recruits HER2 and a trafficking regulatory subnetwork comprising RAB5/RAB7A/GDI2 in HER2+ breast cancer cells. Credit:Science Advances(202
'Molecular glue' stabilizes protein that inhibits development of non-small cell lung cancer

'Molecular glue' stabilizes protein that inhibits development of non-small cell lung cancer

by Ananya Sen,University of MichiganCredit: Jacob Dwyer, Justine Ross, Michigan MedicineLung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80

'Molecular glue' stabilizes protein that inhibits development of non-small cell lung cancer

by Ananya Sen,University of MichiganCredit: Jacob Dwyer, Justine Ross, Michigan MedicineLung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80
Population-based lung cancer screening can reduce mortality in people who have never smoked, study shows

Population-based lung cancer screening can reduce mortality in people who have never smoked, study shows

byEuropean Society for Medical OncologyCredit: Unsplash/CC0 Public DomainNew evidence from a Chinese cohort presented at theEuropean Lung Cancer Congress (ELCC) 2026shows that one-time low-dose comput

Population-based lung cancer screening can reduce mortality in people who have never smoked, study shows

byEuropean Society for Medical OncologyCredit: Unsplash/CC0 Public DomainNew evidence from a Chinese cohort presented at theEuropean Lung Cancer Congress (ELCC) 2026shows that one-time low-dose comput
Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients

Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainChronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia in the Western Hemisphere, affecting approximately 20

Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainChronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia in the Western Hemisphere, affecting approximately 20
Cancer's hidden 'safety switch': Silencing TAK1 gene could boost immunotherapy performance

Cancer's hidden 'safety switch': Silencing TAK1 gene could boost immunotherapy performance

byLa Trobe UniversityCredit: Pixabay/CC0 Public DomainAustralian researchers have discovered that the TAK1 gene helps cancer cells survive attack from the immune system, revealing a mechanism that may

Cancer's hidden 'safety switch': Silencing TAK1 gene could boost immunotherapy performance

byLa Trobe UniversityCredit: Pixabay/CC0 Public DomainAustralian researchers have discovered that the TAK1 gene helps cancer cells survive attack from the immune system, revealing a mechanism that may
Clinical trial of personalized cancer vaccine demonstrates feasibility, safety, immune activation

Clinical trial of personalized cancer vaccine demonstrates feasibility, safety, immune activation

byHarvard UniversityThe personalized biomaterial-based cancer vaccine consists of a porous biomaterial scaffold the size of an aspirin tablet that is infused with immune cell-recruiting and activating

Clinical trial of personalized cancer vaccine demonstrates feasibility, safety, immune activation

byHarvard UniversityThe personalized biomaterial-based cancer vaccine consists of a porous biomaterial scaffold the size of an aspirin tablet that is infused with immune cell-recruiting and activating